Out-licensing

The eventual end commercialization of our technologies are on the role of our alliances. We continuously develop our internal strengths and capabilities while reaching out to wide and solid international partnerships and collaborations.

Novel use of yeast extract as SSRIs, Application for Diseases, Market Opportunity

Yeast, generally recognized as safe (GRAS) for the human body, contains 50% or more quality proteins, excess minerals, vitamin B, etc., so it has been widely used in the liquor or bakery industry as a source of protein, nucleic acids, enzymes, liquids, vitamins, minerals, etc..  Yeast extracts produced by autolytic enzyme or other proteases have been used as a source of microorganism fermentation media, seasonings, and health foods. 

A yeast extract or yeast-derived bioactive peptide having an activity of selectively inhibiting reuptake of serotonin and norepinephrine , which can be effectively used in preventing or treating various diseases related to reuptake of serotonin and norepinephrine, especially depression, anxiety, stress, fatigue and obesity.

Early Stage

CC	Pat. No.	Pat. Date	Title
US	7473426	2009.01.06	Method for selectively inhibiting reuptake of serotonin and norepinephrine using yeast extract
US	20040101934	2004.05.27	Peptide derived from yeast having activities as anti-tsress, anti-fatigue and brain neurotrophic factor and relaxing premenstrual syndrome and menstrual pain, and preparing process thereof
US	20060140974	2006.06.29	Method for selectively inhibiting reuptake of serotonin and norepinephrine using yeast extract
WO	WO02/067959	2002.09.06	Peptide derived from yeast having activities as anti-tsress, anti-fatigue and brain neurotrophic factor and relaxing premenstrual syndrome and menstrual pain, and prepairing process thereof

Technology transfer, or non-exclusive or exclusive licensing agreement

WO02067959; US7473426